|
HY-12660-10mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-2mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-5mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-50mg
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-12660-1mL
|
MedChemexpress LLC
|
MPI-0479605 [CAS 1246529-32-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-P7765-10ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (75a.a)
|
|
|
|
|
HY-P7765-50ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (75a.a)
|
|
|
|
|
HY-P72786-10ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a)
|
|
|
|
|
HY-P72786-50ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a)
|
|
|
|
|
HY-P7259-10ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a, CHO)
|
|
|
|
|
HY-P7259-100ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a, CHO)
|
|
|
|
|
HY-P7259-2ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a, CHO)
|
|
|
|
|
HY-P7259-50ug
|
MedChemexpress LLC
|
MPIF-1/CCL23, Human (99a.a, CHO)
|
|
|
|
|
HY-139915-10mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-139915-100mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-139915-25mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-139915-5mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-139915-50mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-103454-5mg
|
MedChemexpress LLC
|
MPP (dihydrochloride) [CAS 911295-24-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-103454B-10mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103454B-100mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103454B-25mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103454B-5mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-103454B-50mg
|
MedChemexpress LLC
|
MPP (hydrochloride) [CAS 2863676-89-3]
|
|
Cancer-programmed cell death
|
|
|
HY-136149A-25mg
|
MedChemexpress LLC
|
Mpro inhibitor N3 (hemihydrate)
|
|
COVID-19-anti-virus
|
|
